Zymeworks (NASDAQ:ZYME) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.41) by 26.83 percent. This is a 28.57 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $27.11 million which beat the analyst consensus estimate of $20.65 million by 31.26 percent. This is a 170.29 percent increase over sales of $10.03 million the same period last year.